Ghost Tree Capital, LLC Viridian Therapeutics, Inc.\De Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

A detailed history of Ghost Tree Capital, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Ghost Tree Capital, LLC holds 75,000 shares of VRDN stock, worth $1.48 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

75,000

Previous 587,708 87.24%

Holding current value

$1.48 Million

Previous $7.65 Million 77.69%

% of portfolio

0.64%

Previous 3.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.16 - $23.33 $6.23 Million - $12 Million	-512,708 Reduced 87.24%	75,000 $1.71 Million
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.26 $432,587 - $643,659	-37,292 Reduced 5.97%	587,708 $7.65 Million
Q1 2024 May 15, 2024	BUY	$17.09 - $23.82 $5.55 Million - $7.74 Million	325,000 Added 108.33%	625,000 $10.9 Million
Q4 2023 Feb 14, 2024	BUY	$11.12 - $22.5 $278,000 - $562,500	25,000 Added 9.09%	300,000 $6.53 Million
Q3 2023 Nov 14, 2023	BUY	$15.16 - $24.7 $530,600 - $864,500	35,000 Added 14.58%	275,000 $4.22 Million
Q2 2023 Aug 14, 2023	BUY	$22.57 - $29.67 $1.47 Million - $1.93 Million	65,000 Added 37.14%	240,000 $5.71 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $250,400 - $376,000	10,000 Added 6.06%	175,000 $4.45 Million
Q4 2022 Feb 14, 2023	SELL	$18.78 - $29.74 $6.95 Million - $11 Million	-370,000 Reduced 69.16%	165,000 $4.82 Million
Q3 2022 Nov 14, 2022	SELL	$10.7 - $25.5 $695,500 - $1.66 Million	-65,000 Reduced 10.83%	535,000 $11 Million
Q2 2022 Aug 15, 2022	BUY	$9.55 - $19.0 $1.28 Million - $2.54 Million	133,597 Added 28.64%	600,000 $6.94 Million
Q1 2022 May 16, 2022	SELL	$16.79 - $20.88 $564,093 - $701,505	-33,597 Reduced 6.72%	466,403 $8.62 Million
Q4 2021 Feb 16, 2022	BUY	$15.65 - $21.5 $2.35 Million - $3.23 Million	150,000 Added 42.86%	500,000 $9.89 Million
Q2 2021 Aug 11, 2021	BUY	$14.34 - $18.67 $717,000 - $933,500	50,000 Added 16.67%	350,000 $6.4 Million
Q1 2021 May 14, 2021	BUY	$15.5 - $24.93 $4.65 Million - $7.48 Million	300,000 New	300,000 $5.01 Million

Others Institutions Holding VRDN

# of Institutions

179

Shares Held

76.8M

Call Options Held

581K

Put Options Held

439K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $789M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account

Ghost Tree Capital, LLC Viridian Therapeutics, Inc.\De Transaction History